Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 97
Filter
1.
J Dent Res ; 97(6): 709-716, 2018 06.
Article in English | MEDLINE | ID: mdl-29489424

ABSTRACT

Lymph nodal disease (LN+) is the most significant prognostic factor of oral squamous cell carcinoma (OSCC). Current risk indicator(s) for guiding elective neck dissection (END) is insufficient for clinically node-negative (cN0) patients, resulting in under- or overtreatment. While the role of immunological events in tumorigenesis and metastasis is evident, the prognostic implication in OSCC remains unclear. The study objective was to investigate large-scale immune-related gene expression and determine its prognostic value on node-free survival (NFS). We analyzed patients who received intent-to-cure surgery with at least 3 y of follow-up and known outcome of LN through a pan-Canadian surgical trial. Total RNA was extracted from surgical tissues with >70% tumor content and analyzed on a 730-gene panel (NanoString nCounter® PanCancer Immune Panel). We first profiled gene expression in a fresh-frozen (FF) discovery set to identify differentially expressed (DE) genes, which were then used in unsupervised clustering analysis to identify patient subgroups. The prognostic value of the identified DE genes was then validated on formalin-fixed, paraffin-embedded (FFPE) samples. A total of 177 RNA samples were derived from 89 FF and 88 FFPE surgical tissues, of which 45 (51%) and 40 (45%), respectively, were from patients who developed LN+. We identified 6 DE genes overexpressed in LN+ tumors (false discovery rate <0.001; log2 fold change >1). Clustering analysis separated the patients into 2 subgroups (CM1, CM2), with CM2 exhibiting significantly increased expression and worse 5-y NFS rate (28%; P < 0.001). The prognostic value of these 6 candidate genes was validated on FFPE samples, which were also separated into 2 distinct prognostic groups, confirming the association between increased gene expression and poor 5-y NFS (CM1, 70.3%; CM2, 43.3%; P = 0.01). This is the first study identifying a panel of immune-related genes associated with NFS that can potentially be used clinically stratifying the risk of LN+ at the time of OSCC diagnosis.


Subject(s)
Carcinoma, Squamous Cell/diagnosis , Mouth Neoplasms/diagnosis , Adult , Aged , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Female , Gene Expression Regulation, Neoplastic , Humans , Lymphatic Metastasis/diagnosis , Male , Middle Aged , Mouth Neoplasms/metabolism , Mouth Neoplasms/pathology , Prognosis , Proportional Hazards Models , Transcriptome
2.
Heart Lung Circ ; 27(5): 552-559, 2018 May.
Article in English | MEDLINE | ID: mdl-29402692

ABSTRACT

AIM: We now know that 20-40% of patients with a single ventricle will develop heart failure after the second decade post-Fontan surgery. However, we remain unable to risk-stratify the cohort to identify patients at highest risk of late failure and death. We conducted a systematic review of all reported late outcomes for patients with a Fontan circulation to identify predictors of late death. METHODS: We searched MEDLINE, Embase and PubMed with subject terms ("single ventricle", "Hypoplastic left heart syndrome", "congenital heart defects" or "Fontan procedure") AND ("heart failure", "post-operative complications", "death", "cause of death", "transplantation" or "follow-up studies") for relevant studies between January 1990 and December 2015. Variables identified as significant predictors of late death on multivariate analysis were collated for meta-analysis. Survival data was extrapolated from Kaplan-Meier survival curves to generate a distribution-free summary survival curve. RESULTS: Thirty-four relevant publications were identified, with a total of 7536 patients included in the analysis. Mean follow-up duration was 114 months (range 24-269 months). There were 688 (11%) late deaths. Predominant causes of death were late Fontan failure (34%), sudden death (19%) and perioperative death (16%). Estimated mean survival at 5, 10 and 20 years post Fontan surgery were 95% (95%CI 93-96), 91% (95%CI 89-93) and 82% (95%CI 77-85). Significant predictors of late death include prolonged pleural effusions post Fontan surgery (HR1.18, 95%CI 1.09-1.29, p<0.001), protein losing enteropathy (HR2.19, 95%CI 1.69-2.84, p<0.001), increased ventricular end diastolic volume (HR1.03 per 10ml/BSA increase, 95%CI 1.02-1.05, p<0.001) and having a permanent pacemaker (HR12.63, 95%CI 6.17-25.86, p<0.001). CONCLUSIONS: Over 80% of patients who survive Fontan surgery will be alive at 20 years. Developing late sequelae including protein losing enteropathy, ventricular dysfunction or requiring a pacemaker predict a higher risk of late death.


Subject(s)
Cause of Death/trends , Fontan Procedure , Heart Defects, Congenital/surgery , Heart Failure , Registries , Global Health , Heart Failure/etiology , Heart Failure/mortality , Heart Failure/psychology , Humans , Risk Factors , Survival Rate/trends
3.
Med Phys ; 42(8): 4484-96, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26233178

ABSTRACT

PURPOSE: Accurate visualization of lung motion is important in many clinical applications, such as radiotherapy of lung cancer. Advancement in imaging modalities [e.g., computed tomography (CT) and MRI] has allowed dynamic imaging of lung and lung tumor motion. However, each imaging modality has its advantages and disadvantages. The study presented in this paper aims at generating synthetic 4D-CT dataset for lung cancer patients by combining both continuous three-dimensional (3D) motion captured by 4D-MRI and the high spatial resolution captured by CT using the authors' proposed approach. METHODS: A novel hybrid approach based on deformable image registration (DIR) and finite element method simulation was developed to fuse a static 3D-CT volume (acquired under breath-hold) and the 3D motion information extracted from 4D-MRI dataset, creating a synthetic 4D-CT dataset. RESULTS: The study focuses on imaging of lung and lung tumor. Comparing the synthetic 4D-CT dataset with the acquired 4D-CT dataset of six lung cancer patients based on 420 landmarks, accurate results (average error <2 mm) were achieved using the authors' proposed approach. Their hybrid approach achieved a 40% error reduction (based on landmarks assessment) over using only DIR techniques. CONCLUSIONS: The synthetic 4D-CT dataset generated has high spatial resolution, has excellent lung details, and is able to show movement of lung and lung tumor over multiple breathing cycles.


Subject(s)
Imaging, Three-Dimensional/methods , Lung Neoplasms/pathology , Lung/pathology , Magnetic Resonance Imaging/methods , Multimodal Imaging/methods , Tomography, X-Ray Computed/methods , Computer Simulation , Datasets as Topic , Feasibility Studies , Finite Element Analysis , Lung/diagnostic imaging , Lung Neoplasms/diagnostic imaging , Motion , Respiration
4.
Biochem J ; 460(2): 283-93, 2014 Jun 01.
Article in English | MEDLINE | ID: mdl-24646189

ABSTRACT

Pseudomonas putida GPo1 alkane hydroxylase (AlkB) is an integral membrane protein that catalyses the hydroxylation of medium-chain alkanes (C3-C12). 1-Octyne irreversibly inhibits this non-haem di-iron mono-oxygenase under turnover conditions, suggesting that it acts as a mechanism-based inactivator. Upon binding to the active site, 1-octyne is postulated to be oxidized to an oxirene that rapidly rearranges to a reactive ketene which covalently acylates nearby residues, resulting in enzyme inactivation. In analysis of inactivated AlkB by LC-MS/MS, several residues exhibited a mass increase of 126.1 Da, corresponding to the octanoyl moiety derived from oxidative activation of 1-octyne. Mutagenesis studies of conserved acylated residues showed that Lys18 plays a critical role in enzyme function, as a single-point mutation of Lys18 to alanine (K18A) completely abolished enzymatic activity. Finally, we present a computational 3D model structure of the transmembrane domain of AlkB, which revealed the overall packing arrangement of the transmembrane helices within the lipid bilayer and the location of the active site mapped by the 1-octyne modifications.


Subject(s)
Alkanes/metabolism , Cytochrome P-450 CYP4A/metabolism , Pseudomonas putida/enzymology , Alkynes/metabolism , Alkynes/pharmacology , Catalytic Domain , Cytochrome P-450 CYP4A/antagonists & inhibitors , Cytochrome P-450 CYP4A/chemistry , Cytochrome P-450 CYP4A/genetics , Hydrophobic and Hydrophilic Interactions , Hydroxylation , Lysine/chemistry , Membrane Proteins/metabolism , Models, Molecular , Pseudomonas putida/genetics , Tandem Mass Spectrometry
5.
IEEE J Biomed Health Inform ; 18(3): 969-77, 2014 May.
Article in English | MEDLINE | ID: mdl-24058039

ABSTRACT

Dynamic three-dimensional (3-D) (four-dimensional, 4-D) magnetic resonance (MR) imaging is gaining importance in the study of pulmonary motion for respiratory diseases and pulmonary tumor motion for radiotherapy. To perform quantitative analysis using 4-D MR images, segmentation of anatomical structures such as the lung and pulmonary tumor is required. Manual segmentation of entire thoracic 4-D MRI data that typically contains many 3-D volumes acquired over several breathing cycles is extremely tedious, time consuming, and suffers high user variability. This requires the development of new automated segmentation schemes for 4-D MRI data segmentation. Registration-based segmentation technique that uses automatic registration methods for segmentation has been shown to be an accurate method to segment structures for 4-D data series. However, directly applying registration-based segmentation to segment 4-D MRI series lacks efficiency. Here we propose an automated 4-D registration-based segmentation scheme that is based on spatiotemporal information for the segmentation of thoracic 4-D MR lung images. The proposed scheme saved up to 95% of computation amount while achieving comparable accurate segmentations compared to directly applying registration-based segmentation to 4-D dataset. The scheme facilitates rapid 3-D/4-D visualization of the lung and tumor motion and potentially the tracking of tumor during radiation delivery.


Subject(s)
Imaging, Three-Dimensional/methods , Magnetic Resonance Imaging/methods , Case-Control Studies , Humans , Lung Neoplasms/pathology , Thorax/pathology
6.
Oral Dis ; 19(5): 440-51, 2013 Jul.
Article in English | MEDLINE | ID: mdl-24079944

ABSTRACT

With the unreliability of epithelial dysplasia as a predictor to determine the risk of future malignant development, subjectivity associated in evaluating dysplasia by pathologists and paucity of biomarkers that could accurately predict the progression risks in oral potentially malignant disorders (PMDs), eradication of the lesions appears to be the most desirable approach to minimize the risk of invasive cancer formation. Interventions, such as surgery and chemoprevention, have not shown promising long-term results in the treatment of these lesions, and lack of guidelines and general consensus on their management has incited much anxiety and doubts in both patients and community clinicians. Topical photodynamic therapy (PDT) is a minimally invasive and minimally toxic technique that in recent years has shown great promise in the management of PMDs. In this review, we describe the historical developments in the field of PDT, its basic mechanisms, as well as related clinical studies, and its challenges in the management of oral PMDs. Based on its high efficacy and low side effects, its high patient acceptance/compliance, the simplicity of the procedure and its minimal pretreatment preparation, topical PDT is believed to have potential to play an important role in the management of PMDs, especially of the low-grade dysplasia.


Subject(s)
Mouth Neoplasms/drug therapy , Photochemotherapy/methods , Humans , Prospective Studies
7.
Oral Oncol ; 49(6): 582-90, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23415144

ABSTRACT

OBJECTIVES: We investigated the potential use of real-time confocal microscopy in the non-invasive detection of occult oral potentially malignant lesions. Our objectives were to select the best fluorescence contrast agent for cellular morphology enhancement, to build an atlas of confocal microscopic images of normal human oral mucosa, and to determine the accuracy of confocal microscopy to recognize oral high-grade dysplasia lesions on live human tissue. MATERIALS AND METHODS: Five clinically used fluorescent contrast agents were tested in vitro on cultured human cells and validated ex vivo on human oral mucosa. Images acquired ex vivo from normal and diseased human oral biopsies with bench-top fluorescent confocal microscope were compared to conventional histology. Image analyzer software was used as an adjunct tool to objectively compare high-grade dysplasia versus low-grade dysplasia and normal epithelium. RESULTS: Acriflavine Hydrochloride provided the best cellular contrast by preferentially staining the nuclei of the epithelium. Using topical application of Acriflavine Hydrochloride followed by confocal microscopy, we could define morphological characteristics of each cellular layer of the normal human oral mucosa, building an atlas of histology-like images. Applying this technique to diseased oral tissue specimen, we were also able to accurately diagnose the presence of high-grade dysplasia through the increased cellularity and changes in nuclear morphological features. Objective measurement of cellular density by quantitative image analysis was a strong discriminant to differentiate between high-grade dysplasia and low-grade dysplasia lesions. CONCLUSIONS: Pending clinical investigation, real-time confocal microscopy may become a useful adjunct to detect precancerous lesions that are at high risk of cancer progression, direct biopsy and delineate excision margins.


Subject(s)
Contrast Media , Microscopy, Confocal/methods , Mouth Neoplasms/diagnosis , Acriflavine , Adult , Aged , Aged, 80 and over , Cell Line , Female , Fluorescent Dyes , Humans , Male , Middle Aged , Mouth Mucosa/pathology
8.
Article in English | MEDLINE | ID: mdl-23312920

ABSTRACT

INTRODUCTION: The solitary keratocystic odontogenic tumor (KCOT) is a neoplasm, which recurs in 28% of cases. The purpose of this study is to determine whether clinicoradiographic features can predict recurrence. MATERIAL AND METHODS: From 2000 to 2009, 106 solitary KCOTs were retrieved from the Oral Biology Service of British Columbia. Among 58 KCOTs including all recurrent KCOTs (rKCOT) and nonrecurrent KCOTs (nrKCOT) (followed up for at least 5 years), only 29 had radiographs (rKCOT, 18; nrKCOT, 11). RESULTS: Patients with recurrences were significantly older than those without. Interestingly, those cases, which were considered KCOTs before surgery, were significantly more likely not to recur within 5 years of follow-up. Most radiological features did not differ between nrKCOT and rKCOT on the basis of panoramic radiography only.


Subject(s)
Odontogenic Tumors/diagnosis , Adult , Biopsy , British Columbia , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Neoplasm Recurrence, Local , Odontogenic Cysts/diagnosis , Odontogenic Cysts/pathology , Odontogenic Cysts/surgery , Odontogenic Tumors/pathology , Odontogenic Tumors/surgery , Predictive Value of Tests , Radiography, Panoramic , Treatment Outcome
9.
ACS Chem Biol ; 8(3): 506-12, 2013 Mar 15.
Article in English | MEDLINE | ID: mdl-23214419

ABSTRACT

By using a phage display derived peptide as an initial template, compounds have been developed that are highly specific against Mdm2/Mdm4. These compounds exhibit greater potency in p53 activation and protein-protein interaction assays than a compound derived from the p53 wild-type sequence. Unlike Nutlin, a small molecule inhibitor of Mdm2/Mdm4, the phage derived compounds can arrest cells resistant to p53 induced apoptosis over a wide concentration range without cellular toxicity, suggesting they are highly suitable for cyclotherapy.


Subject(s)
Peptides/pharmacology , Tumor Suppressor Protein p53/metabolism , Cell Cycle Proteins , Humans , Models, Molecular , Nuclear Proteins/antagonists & inhibitors , Nuclear Proteins/metabolism , Peptides/chemistry , Proto-Oncogene Proteins/antagonists & inhibitors , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-mdm2/antagonists & inhibitors , Proto-Oncogene Proteins c-mdm2/metabolism , Tumor Suppressor Protein p53/chemistry
10.
Vaccine ; 30(49): 7105-10, 2012 Nov 19.
Article in English | MEDLINE | ID: mdl-23022400

ABSTRACT

Currently, infections of hand, foot and mouth disease (HFMD) due to Human Enterovirus 71 (EV71) cannot be prevented or treated, as there are no suitable vaccines or antiviral drugs. This study aimed to identify potential vaccine candidates for EV71 using in silico analysis of its viral capsid proteins. A combined in silico approach utilizing computational hidden Markov model (HMM), propensity scale algorithm, and artificial learning, identified three 15-mer structurally conserved B-cell epitope candidates lying within the EV71 capsid proteins. Peptide vaccine candidates incorporating a target B-cell epitope and a promiscuous T-cell epitope from the related polio virus were synthesized using solid-phase Fmoc chemistry. Inbred BALB/C mice which were inoculated with two 10µg doses of the synthetic peptide, generated anti-peptide antibodies. Purified IgG isolated from pooled sera of the inoculated mice neutralized EV71 infections in vitro. Furthermore, these neutralizing antibodies were cross-reactive against other members of the Picornaviridae family, demonstrating greater than 50% virus neutralization. This indicates that the current approach is promising for the development of synthetic peptide-based vaccine candidates against Picornaviridae. Development of effective vaccines is of paramount importance in managing the disease in the Asia Pacific regions where this virus is endemic and has significant social, economic and public health ramifications.


Subject(s)
Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , Enterovirus A, Human/immunology , Epitopes, B-Lymphocyte/immunology , Animals , Antibodies, Neutralizing/blood , Antibodies, Viral/blood , Capsid Proteins/genetics , Capsid Proteins/immunology , Computational Biology , Cross Reactions , Enterovirus A, Human/genetics , Epitopes, B-Lymphocyte/genetics , Humans , Immunoglobulin G/blood , Immunoglobulin G/immunology , Mice , Mice, Inbred BALB C , Vaccines, Subunit/administration & dosage , Vaccines, Subunit/chemical synthesis , Vaccines, Subunit/immunology
11.
J Dent Res ; 91(1): 52-7, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21990607

ABSTRACT

Subgroups of patients with oral pre-malignant lesions (OPLs) are at extremely high risk for developing invasive cancer in spite of surgical excision. The objective of this study was to evaluate the utility of specific genes and their associated centromeres as markers to stratify OPLs for their cancer risk. Samples used in this study included 35 oral dysplasia with known outcome and 20 normal oral mucosa. Of the dysplasias, 20 were from an ongoing longitudinal study showing progression. The remaining 15 cases (2 of which progressed) were chosen from the population-based, provincial BC Oral Biopsy Service (OBS). Copy number alterations at EGFR, CEP7, CCND1, and CEP11 were evaluated by fluorescent in situ hybridization (FISH). There was no significant difference in demographics between progressors and non-progressors. Specific FISH profiles at these genes and their corresponding centromeres were associated with progression. High gene gain of CCND1 was associated with an 8-fold elevated risk of progression compared with those with no gain in time-to-progression analysis. Numerical alterations of EGFR and CCND1 and their centromeres might be an effective means for identifying OPLs at risk. Future studies will expand on this analysis and set the stage for application of this approach in routine clinical practice.


Subject(s)
Carcinoma, Squamous Cell/pathology , Cell Transformation, Neoplastic/genetics , Gene Dosage/genetics , Mouth Neoplasms/pathology , Precancerous Conditions/pathology , Biomarkers, Tumor , Carcinoma, Squamous Cell/genetics , Case-Control Studies , Centromere/pathology , Chromosomal Instability/genetics , Cyclin D1/genetics , Disease Progression , ErbB Receptors/genetics , Female , Humans , In Situ Hybridization, Fluorescence , Kaplan-Meier Estimate , Male , Middle Aged , Mouth Mucosa/pathology , Mouth Neoplasms/genetics , Polyploidy , Precancerous Conditions/genetics , Proportional Hazards Models , Retrospective Studies , Risk Factors , Sensitivity and Specificity
12.
J Dent Res ; 91(5): 440-6, 2012 May.
Article in English | MEDLINE | ID: mdl-22166582

ABSTRACT

Oral cancer is one of the most commonly diagnosed malignancies worldwide. Its dismal five-year survival rate of ~50% has barely changed for decades. A better understanding of the molecular basis of tumorigenesis - with particular emphasis on disease initiation and progression - is needed to improve clinical outcomes, since this will facilitate the development of drugs and management strategies based on the specific genetic changes underpinning disease behaviors. MicroRNAs (miRNAs), a class of short non-coding RNAs that down-regulate gene expression, have been demonstrated to play essential roles in human cancers. miRNA deregulation has been observed in many tumor types and is implicated in oncogenic cell processes, including proliferation, survival, apoptosis, metastasis, and chemoresistance. In addition, miRNA alterations have been associated with specific clinical phenotypes such as disease progression or recurrence, development of metastases, and post-operative survival. Recent studies have explored the utility of miRNAs as diagnostic and prognostic tools and as potential therapeutic targets. Herein, we discuss miRNA biology and provide a summary of the key findings on the role of miRNAs in oral malignancies.


Subject(s)
Carcinoma, Squamous Cell/genetics , Gene Expression Regulation, Neoplastic/physiology , MicroRNAs/physiology , Mouth Neoplasms/genetics , Biomarkers, Tumor/genetics , Cell Transformation, Neoplastic/genetics , Drug Resistance, Neoplasm/genetics , Gene Expression Regulation, Neoplastic/genetics , Genes, Tumor Suppressor , Humans , MicroRNAs/genetics , Oncogenes/genetics , Prognosis
14.
Neurogastroenterol Motil ; 23(11): e489-96, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21366805

ABSTRACT

BACKGROUND: Acute stress exacerbates heartburn in gastroesophageal reflux disease (GERD) patients by enhancing the perceptual responses to intraesophageal acid. The aim of the study was to determine if antireflux treatment can still alter stimulus response functions to acid in patients undergoing acute stress as compared with placebo. METHODS: Symptomatic GERD patients with erosive esophagitis (EE) or an abnormal pH test were included. Patients underwent stimulus response functions to intraesophageal acid perfusion using the mental arithmetic stressor test. Thereafter, patients were randomized (2 : 1 ratio) to either esomeprazole 40 mg once daily or placebo for 8 weeks. On the last day of treatment, subjects underwent stimulus response functions to intraesophageal acid perfusion using a similar stressor as baseline. KEY RESULTS: A total of 31 patients were randomized into the treatment arm (mean age 48.6 ± 2.8, M/F 21/10) and 16 into the placebo arm (mean age 52.3 ± 4.3, M/F 12/4). In the esomeprazole group, there was a significant increase in lag time to symptom perception (P = 0.02) and decreased in intensity rating (P = 0.01) as well as acid perfusion sensitivity score (P = 0.01). There was no significant difference in any of the stimulus response functions to acid in the placebo group between baseline and treatment. Interpersonal sensitivity was the only independent clinical predictor factor for response to antireflux treatment. CONCLUSIONS & INFERENCES: Long-term antireflux treatment with a proton pump inhibitor is effective in reducing esophageal perception responses to acid during acute stress.


Subject(s)
Anti-Ulcer Agents/therapeutic use , Esomeprazole/therapeutic use , Gastroesophageal Reflux/drug therapy , Gastroesophageal Reflux/physiopathology , Gastroesophageal Reflux/psychology , Stress, Psychological/psychology , Esophageal pH Monitoring , Esophagus/pathology , Humans , Hydrochloric Acid/administration & dosage , Placebos/therapeutic use , Quality of Life , Surveys and Questionnaires
15.
Intern Med J ; 41(8): 623-9, 2011 Aug.
Article in English | MEDLINE | ID: mdl-19849750

ABSTRACT

AIM: Premature discontinuation of antiplatelet therapy is an independent predictor of late stent thrombosis. We sought to determine the prevalence and predictors of premature discontinuation of antiplatelet therapy after drug-eluting stent implantation among patients in Asia. METHODS: A total of 207 consecutive patients who underwent drug-eluting stent implantation at our institution was followed up after 1 year. Premature discontinuation of antiplatelet therapy was defined as omission of aspirin and/or clopidogrel for 1 week or more. RESULTS: Four (1.9%) patients died and the remaining 203 patients formed the study population. Prevalence of premature discontinuation of antiplatelet therapy was 12.8% (n= 26, aspirin, n= 12; clopidogrel, n= 9; both, n= 5). The median duration between stent implantation and discontinuation of antiplatelet therapy was 2.8 months. Reasons for discontinuation included cost (n= 1), gastric discomfort (n= 1), allergy (n= 3), bleeding (n= 3), advice from doctors (n= 7) and no reason (n= 11). Logistic regression showed that living alone was the only independent predictor of premature discontinuation of dual antiplatelet therapy (50.0% vs 11.3%, P= 0.001). CONCLUSION: Among Asian patients who have undergone drug-eluting stent implantation, 12.8% discontinued dual antiplatelet therapy within 12 months. Living alone is associated with a fivefold increase in risk of premature drug discontinuation.


Subject(s)
Asian People/ethnology , Drug-Eluting Stents , Patient Compliance/ethnology , Platelet Aggregation Inhibitors/administration & dosage , Social Environment , Aged , Drug Therapy, Combination , Female , Follow-Up Studies , Humans , Male , Middle Aged , Predictive Value of Tests , Prevalence , Prospective Studies , Registries
16.
Intern Med J ; 41(12): 809-14, 2011 Dec.
Article in English | MEDLINE | ID: mdl-20546061

ABSTRACT

BACKGROUND: Previous studies in Western countries found that the emergency medical service (EMS) was under-used in patients with myocardial infarction. AIM: We sought to determine the prevalence of immediate EMS utilisation among Singapore patients presenting with ST-segment elevation myocardial infarction (STEMI), and correlated the use of the EMS with the symptom-to-balloon and door-to-balloon times. METHODS: We studied 252 patients admitted with STEMI to our institution from August 2008 to September 2009. Information regarding demographic characteristics, whether EMS was used, reperfusion procedural details and mortality rates were collected prospectively. RESULTS: Among the recruited patients, 89 (35.3%) used the EMS (EMS group) and 163 (64.7%) did not use the EMS (non-EMS group). In the latter group, 98 (60.1%) arrived at our institution through their own transport, 56 (34.4%) first consulted general practitioners, and 9 (5.5%) initially consulted another hospital without acute medical services. Among the 245 (out of 252, 97.2%) patients who received percutaneous coronary intervention (PCI), the EMS group was more likely to undergo primary PCI (P= 0.003) while the non-EMS group was more likely to undergo non-urgent PCI (P= 0.002). In patients who underwent primary PCI, the EMS group had a shorter symptom-to-balloon time (average difference 81.6 min, P= 0.002). The door-to-balloon time was similar for both groups. CONCLUSION: Despite the availability of a centralised EMS, 64.7% of patients with STEMI did not contact EMS at presentation. These patients were less likely to receive primary PCI and had a significantly longer symptom-to-balloon time.


Subject(s)
Emergency Medical Services/statistics & numerical data , Myocardial Infarction/epidemiology , Myocardial Infarction/therapy , Adult , Cohort Studies , Female , Humans , Male , Middle Aged , Myocardial Ischemia/epidemiology , Myocardial Ischemia/therapy , Prevalence , Prospective Studies , Singapore/epidemiology , Surveys and Questionnaires , Time Factors
17.
J Clin Microbiol ; 49(1): 419-22, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21084510

ABSTRACT

A high-throughput multiplex bead suspension array was developed for the rapid subgenogrouping of EV71 strains, based on single nucleotide polymorphisms observed within the VP1 region with a high sensitivity as low as 1 PFU. Of 33 viral isolates and 55 clinical samples, all EV71 strains were successfully detected and correctly subgenogrouped.


Subject(s)
Enterovirus A, Human/genetics , Enterovirus A, Human/isolation & purification , Enterovirus Infections/diagnosis , Virology/methods , Enterovirus Infections/virology , Humans , Microspheres , Molecular Sequence Data , Oligonucleotides/genetics , RNA, Viral/genetics , Sequence Analysis, DNA
18.
Int J Infect Dis ; 14(12): e1076-81, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20952237

ABSTRACT

BACKGROUND: During 2008, Singapore experienced its largest ever outbreak of hand, foot and mouth disease (HFMD), resulting in 29686 cases, including four cases of encephalitis and one fatality. METHODS: A total of 51 clinical specimens from 43 patients with suspected HFMD at the National University Hospital, Singapore were collected for virus isolation and identification by reverse transcription polymerase chain reaction (RT-PCR) and sequencing. RESULTS: Enteroviruses were identified in 34 samples (66.7%), with 11 samples (21.6%) being positive for enterovirus 71 (EV71). Other non-EV71 enteroviruses (including coxsackievirus A4, A6, A10, and A16) were identified in 23 samples (45.1%). The most prevalent virus serotypes were CA6, CA10, and EV71. CA6 and CA10 accounted for 35.3% of all HFMD cases, which may explain the high transmissibility and low fatality that characterized this unprecedented epidemic associated with relatively mild disease. Phylogenetic analyses of 10 circulating EV71 strains indicated that they belonged to two subgenogroups, i.e., B5 (80%) and C2 (20%). The VP1 sequences of the 2008 EV71 strains also exhibited continuous mutations during the outbreak, reflecting the relatively high mutation rate of the EV71 capsid protein, which may have implications for future vaccine development. CONCLUSIONS: A safe and effective vaccine against EV71 is certainly warranted in view of its potential neurovirulence and its role in HFMD epidemics of recurring frequency with resultant fatalities in Asia, as well as other parts of the world.


Subject(s)
Disease Outbreaks , Enterovirus A, Human/genetics , Enterovirus/classification , Enterovirus/genetics , Hand, Foot and Mouth Disease/epidemiology , Molecular Epidemiology , Base Sequence , Child, Preschool , Encephalitis, Viral/epidemiology , Encephalitis, Viral/virology , Enterovirus/isolation & purification , Enterovirus A, Human/isolation & purification , Enterovirus Infections/epidemiology , Enterovirus Infections/virology , Female , Hand, Foot and Mouth Disease/virology , Humans , Male , Molecular Sequence Data , Phylogeny , RNA, Viral/analysis , RNA, Viral/genetics , RNA, Viral/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA , Singapore/epidemiology
19.
Aliment Pharmacol Ther ; 32(6): 787-94, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20670218

ABSTRACT

BACKGROUND: A significant increase in oesophageal acid exposure during early recumbent period has been demonstrated. AIM: To determine if acid reflux during the early recumbent period occurs in the recumbent-asleep or recumbent-awake period using a novel integrative actigraphy and pH programme. METHOD: Thirty-nine subjects with heartburn at least three times a week were included. Subjects underwent pH testing concomitantly with actigraphy. Simultaneously recorded actigraphy and pH data were incorporated using a novel integrative technique to determine sleep and awake periods. Characteristics of acid reflux were compared between the recumbent-awake and recumbent-asleep periods. RESULTS: Seventeen (44.7%) subjects had acid reflux events during recumbent-awake period as compared to seven (18.4%) in the corresponding recumbent-asleep period (P = 0.046). The mean number of acid reflux events in recumbent-awake period was significantly higher than in the corresponding recumbent-asleep period (8.1 +/- 4.4 vs. 3.2 +/- 1.5, P < 0.001). In the recumbent-awake period, 38.4% of acid reflux events were associated with GERD-related symptoms as compared with 3.7% of acid reflux events during the corresponding recumbent-asleep period (P = 0.01). CONCLUSION: Increased acid reflux in the early recumbent period occurs primarily during the recumbent-awake and not during the recumbent-asleep period.


Subject(s)
Actigraphy/methods , Circadian Rhythm , Esophageal pH Monitoring , Gastroesophageal Reflux/physiopathology , Female , Gastric Acidity Determination , Humans , Male , Middle Aged , Severity of Illness Index , Sleep , Surveys and Questionnaires
20.
Int J Oral Maxillofac Surg ; 39(9): 878-82, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20605411

ABSTRACT

The aim of this research is to analyze the prevalence of dentigerous cysts (DCs) in a population-based cohort in British Columbia, Canada, and to report unusual cases associated with DC. The database of the British Columbia Oral Biopsy Service was searched from 1998 to 2007. 2082 histologically confirmed DCs from 2029 patients were retrieved and retrospectively analyzed for incidence, age, gender and ethnicity. The results show that this is a common jaw cyst with male predilection, has a peak incidence in younger adults and is more common in Caucasians. Multiple DCs, representing 2.5% of the cases, are not associated with any syndromes or systemic conditions. 0.5% DCs were associated with other cysts or tumours at the same site or the opposite side of the jaw. The authors report the first series of cases presenting clinically as bilateral DCs, but histologically as an odontogenic tumour or another type of odontogenic cyst. DCs can co-exist with other more serious conditions, such as odontogenic keratocyst or cystic ameloblastoma. This association with more significant conditions indicates the importance of histologically confirming any jaw cyst, even when it presents clinically as a classic DC.


Subject(s)
Dentigerous Cyst/epidemiology , Mandibular Diseases/pathology , Maxillary Diseases/pathology , Adolescent , Adult , Age Distribution , Aged , British Columbia/epidemiology , Child , Cohort Studies , Dentigerous Cyst/pathology , Dentigerous Cyst/therapy , Female , Functional Laterality , Humans , Male , Mandibular Diseases/epidemiology , Mandibular Diseases/therapy , Maxillary Diseases/epidemiology , Maxillary Diseases/therapy , Middle Aged , Retrospective Studies , Sex Distribution , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...